Dermatitis News

The American Academy of Dermatology announced the results of its annual election, including Jane M. Grant-Kels, MD, FAAD, as vice president-elect and four new board members.

The American Academy of Dermatology announced that George J. Hruza, MD, MBA, FAAD, has been elected president-elect of the academy.

The FDA has approved Dupixent injection to treat adults with moderate-to-severe atopic dermatitis whose disease in not adequately controlled with topical therapies or when those therapies are not advisable.

New therapies for hyperhidrosis was among the top-viewed Video Perspectives from the American Academy of Dermatology Annual Meeting in Washington, DC.

BioPharmX Corp. reported financial results for its fourth quarter and for the fiscal year ended Jan. 31, 2017, as well as research highlights of BPX-01, its topical gel formulation of minocycline.

Novan has announced changes to its executive management team, including the appointment of Paula Brown Stafford to the newly created position of chief development officer.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, AAD President Henry W. Lim, MD, FAAD, outlines his vision for the academy in the upcoming year.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Seemal R. Desai, MD, FAAD, discusses highlights from the meeting’s Therapeutic Hotline session, which he directed.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Karen Edison, MD, FAAD, discusses the AAD’s SkinSerious campaign.

ORLANDO, Fla. — In a video perspective from the American Academy of Dermatology Annual Meeting, Henry W. Lim, MD, FAAD, discusses the economic burden of skin disease in the United States.